Tet family of 5-methylcytosine dioxygenases in mammalian development, J Hum Genet, vol.58, pp.421-427, 2013. ,
TETonic shift: Biological roles of TET proteins in DNA demethylation and transcription, Nat Rev Mol Cell Biol, vol.14, pp.341-356, 2013. ,
Uncovering the role of 5-hydroxymethylcytosine in the epigenome, Nat Rev Genet, vol.13, pp.7-13, 2011. ,
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of ?-ketoglutaratedependent dioxygenases, Cancer Cell, vol.19, pp.17-30, 2011. ,
TET proteins and the control of cytosine demethylation in cancer, Genome, vol.7, p.9, 2015. ,
Genetic Characterization of Ten-Eleven-Translocation Methylcytosine Dioxygenase Alterations in Human Glioma, J Cancer, vol.6, pp.832-842, 2015. ,
DOI : 10.7150/jca.12010
URL : http://www.jcancer.org/v06p0832.pdf
Role of TET enzymes in DNA methylation, development, and cancer, Genes Dev, vol.30, pp.733-750, 2016. ,
DOI : 10.1101/gad.276568.115
URL : http://genesdev.cshlp.org/content/30/7/733.full.pdf
TET enzymes as oxygendependent tumor suppressors: exciting new avenues for cancer management, Epigenomics, vol.8, pp.1445-1448, 2016. ,
DOI : 10.2217/epi-2016-0126
, TLX induces TET3 expression and inhibits glioblastoma stem cell selfrenewal and tumorigenesis, Nat Commun, vol.7, p.10637
DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NF?B complex in the (de-)methylation of TRAF1, Biochimie, vol.104, pp.36-49, 2014. ,
Identification of TET1 Partners That Control Its DNA-Demethylating Function, Genes Cancer, vol.4, pp.235-241, 2013. ,
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex, Cell Rep, vol.9, pp.48-60, 2014. ,
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas, Am J Pathol, vol.181, pp.675-683, 2012. ,
TET family proteins: New players in gliomas, J Neurooncol, vol.116, pp.429-435, 2014. ,
TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations, J Clin Pathol, vol.64, pp.850-852, 2011. ,
Repression of the expression of TET2 by ZEB1 contributes to invasion and growth in glioma cells, Mol Med Rep, vol.15, pp.2625-2632, 2017. ,
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2, Nat Commun, vol.4, p.2166, 2013. ,
The relationship between repeat resection and overall survival in patients with glioblastoma: A time-dependent analysis, J Neurosurg, vol.5, pp.1-9, 2018. ,
Management of glioblastoma after recurrence: A changing paradigm, J Egypt Natl Cancer Inst, vol.28, pp.199-210, 2016. ,
Advances in epigenetic glioblastoma therapy, Oncotarget, vol.8, pp.18577-18589, 2017. ,